Kindeva Drug Delivery

Kindeva Drug Delivery

Private
Woodbury, MinnesotaHealthcare & Life Scienceshttps://kindevadd.com

Last Round

Grant

8/3/2023

Total Funding Raised

$42.1M

Company Overview

Kindeva Drug Delivery is a contract development and manufacturing organization (CDMO) that specializes in solving complex drug delivery challenges for its pharmaceutical and biotechnology customers.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Medical Devices, Clinical Trials, Defense Tech

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

CDMOcontract development and manufacturing organizationdrug-device combination productsdrug deliverypharma outsourcingpulmonary drug deliverysterile injectablestransdermal deliverycommercial manufacturingautoinjectorsaseptic fill-finishformulation developmenttransdermal patchesmedical countermeasuresmicroneedle arrayssustainable propellants

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kindeva Drug Delivery Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kindeva Drug Delivery Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Grant8/3/2023
Buyout/LBO5/1/2020

Key People

Founding team and executive leadership

Milton Boyer

Chief Executive Officer

Executive Team

Daniel Speciale

Chief Financial Officer

Executive Team

Robert Berg

CFO

Executive Team

David Stevens

Chief Operating (COO) Commercial Officer (CCO)

Executive Team

Kindeva Drug Delivery Investors

Notable investors and investment history

InvestorRounds
Monroe CapitalBuyout/LBO
Altaris, LLCBuyout/LBO
3MBuyout/LBO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 11, 2026

    Mike Cowhig appointed as new Chief Legal Officer.

  • Dec 18, 2025

    Partnering with Nutriband to develop abuse-deterrent fentanyl patch.

Kindeva Drug Delivery Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kindeva Drug Delivery Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kindeva Drug Delivery's valuation, stock price, and market status.

Firmographic Details

HeadquartersWoodbury, Minnesota
Employee Range1,364
Year Founded2020
Last Funding8/3/2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.